Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lyncbio Therapeutics Co., Ltd.

Clinical trials sponsored by Lyncbio Therapeutics Co., Ltd., explained in plain language.

Not yet recruiting 1

New ulcerative colitis drug takes first step: safety check in healthy volunteers

Knowledge-focused Not yet recruiting

This early-stage study tests a new drug called LYNC-101 in 50 healthy adults to see if it is safe and how the body processes it. The drug is being developed for ulcerative colitis, a chronic bowel disease. Participants will receive either the drug or a placebo by IV, in single or…

Phase: PHASE1 • Sponsor: LyncBio Therapeutics Co., Ltd. • Aim: Knowledge-focused

Last updated May 03, 2026 11:48 UTC